Aerie Pharmaceuticals (NSDQ:AERI) has priced an underwritten public offering of $75 million in shares of its common stock.
The Irvine, Calif.-based company also plans to grant underwriters a 30-day option to buy up to $11.3 million in shares of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post Aerie Pharmaceuticals prices $75m public offering appeared first on MassDevice.